Quinn Opportunity Partners’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,327
Closed -$71K 361
2025
Q1
$71K Hold
22,327
﹤0.01% 362
2024
Q4
$119K Hold
22,327
0.01% 330
2024
Q3
$118K Hold
22,327
0.01% 250
2024
Q2
$40.6K Hold
22,327
﹤0.01% 259
2024
Q1
$39.7K Buy
+22,327
New +$39.7K ﹤0.01% 235